Login to Your Account



Too Much Cash? In Biotech?

Maxygen Buying Back Stock; Analysts Say No Trend Here

By Trista Morrison


Monday, November 16, 2009
Maxygen Inc. on Friday became the latest member of a very small biotech cadre that is returning cash to shareholders. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription